Raul R. Rodriguez - 02 Feb 2024 Form 4 Insider Report for RIGEL PHARMACEUTICALS INC (RIGL)

Signature
/s/ Raymond Furey (Attorney-in-Fact)
Issuer symbol
RIGL
Transactions as of
02 Feb 2024
Net transactions value
-$60,082
Form type
4
Filing time
06 Feb 2024, 20:18:16 UTC
Previous filing
25 Jan 2024
Next filing
01 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RIGL Common Stock Sale $25,261 -22,349 -1.1% $1.13 2,067,174 02 Feb 2024 Direct F1, F2
transaction RIGL Common Stock Sale $34,821 -30,545 -1.5% $1.14 2,036,629 05 Feb 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.
F2 The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions ranging from $1.13 to $1.135. Upon request, the Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission staff, full information regarding the shares sold at each such separate price.